The Asean Centre for Biodiversity (ACB) welcomed the appointment of its new executive director, Dr. Jerome L. Montemayor, an educator and peatland expert, who vowed to continue celebrating Asean’s ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

It is set in the heart of downtown Laguna Beach, just steps away from where Metz grew up on the sand at Main Beach nearly a century ago. The sale is in escrow, with officials hoping the deal will ...

Residents of the Laguna town also want their officials to address the deterioration of Laguna Lake, a source of livelihood of lakeside communities LAGUNA, Philippines – In a booming town like ...

Xoted Biotechnology Labs, a subsidiary of DRC Ventures, will establish its new research and development center at The Spark Center at Spartanburg Community College's Tyger River Campus in Duncan.

Unlike Trump’s first term, the pharmaceutical industry is in far more peril than it has ever been in, and the biotech industry needs to ask itself an important question: Where does it fit in ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Shenzhen Genocury Biotech Co., Ltd. is a clinical-stage biotechnology pioneer redefining in vivo cell engineering through its proprietary Vivoexpress™ platform. This modular delivery system ...

the Rahway-based company announced April 29. The Merck Wilmington Biotech facility will house laboratory, manufacturing and warehouse capabilities for the launch and commercial production of ...

Seeking to enhance its presence in cancer drugs and the US, the German drug company Merck KGaA is buying the oncology biotech SpringWorks Therapeutics for $3.9 billion. The deal is expected to ...